EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole-Exome Sequencing Utility and Drug Resistance in a Real-World Epilepsy Cohort from Southern Kazakhstan

Islamkhan Doszhanov, Sandugash Rustemova, Nigara Yerkhojayeva, Nursultan Nurdinov, Rauan Kaiyrzhanov, Aziza Djurabekova, Gulzira Baimakhanova, Nazira Zharkinbekova, Aigerim Togizbayeva, Nurlybek Mombekov

International Journal of Translational Medicine · 21.07.2026 · 6 (3) · 30

DOI: 10.3390/ijtm6030030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Translational Medicine, online erschienen am 21.07.2026. Verfasst von Islamkhan Doszhanov und 9 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: In resource-limited regions, limited access to genetic testing may delay etiological diagnosis in selected patients with epilepsy and complex neurological manifestations, particularly when the phenotype raises suspicion of an underlying genetic etiology. This study aimed to assess the diagnostic value and clinical utility of phenotype-guided WES in selected patients aged ≥17 years with epilepsy and complex neurological manifestations in Southern Kazakhstan and to characterize clinical, therapeutic, and molecular features associated with drug-resistant epilepsy (DRE).

Methods

This observational cohort included 78 patients aged ≥17 years with epilepsy and complex neurological manifestations identified through 25 outpatient medical centers. After enrollment, all patients underwent structured HPO-based phenotyping, assessment of antiseizure medication exposure, seizure burden, treatment response, and proband-only WES. Variants were interpreted according to ACMG/AMP guidelines. Exploratory multivariable logistic regression was used to assess factors associated with DRE.

Results

P/LP variants were identified in 12/78 patients, corresponding to a diagnostic yield of 15.4%. VUS were detected in 16/78 patients (20.5%). DRE was present in 41 patients (52.6%), all of whom were receiving polytherapy. Carbamazepine was the most frequently used antiseizure medication (52/78, 66.7%), followed by valproic acid (32/78, 41.0%) and levetiracetam (20/78, 25.6%). Patients with DRE had earlier seizure onset, more frequent definite structural MRI abnormalities, and a higher proportion of P/LP variants. In the adjusted model, P/LP variant presence and definite structural MRI abnormality were associated with DRE.

Conclusions

Phenotype-guided proband-only WES provided clinically relevant diagnostic information in a real-world epilepsy cohort with complex neurological manifestations in a resource-limited outpatient setting. The observed burden of DRE and polytherapy supports the potential value of integrating therapeutic profiling, neuroimaging, and genomic testing in the etiological evaluation of patients with epilepsy and additional neurological features.

Förderung

  • Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan

Zitieren

APA

Doszhanov, I., Rustemova, S., Yerkhojayeva, N., Nurdinov, N., Kaiyrzhanov, R., Djurabekova, A., Baimakhanova, G., Zharkinbekova, N., Togizbayeva, A., & Mombekov, N. (2026). Whole-Exome Sequencing Utility and Drug Resistance in a Real-World Epilepsy Cohort from Southern Kazakhstan. International Journal of Translational Medicine, 6(3), 30. https://doi.org/10.3390/ijtm6030030

Vancouver

Doszhanov I, Rustemova S, Yerkhojayeva N, Nurdinov N, Kaiyrzhanov R, Djurabekova A, et al. Whole-Exome Sequencing Utility and Drug Resistance in a Real-World Epilepsy Cohort from Southern Kazakhstan. International Journal of Translational Medicine. 2026;6(3):30. doi:10.3390/ijtm6030030

BibTeX
@article{Doszhanov2026,
  author = {Doszhanov, Islamkhan and Rustemova, Sandugash and Yerkhojayeva, Nigara and Nurdinov, Nursultan and Kaiyrzhanov, Rauan and Djurabekova, Aziza and Baimakhanova, Gulzira and Zharkinbekova, Nazira and Togizbayeva, Aigerim and Mombekov, Nurlybek},
  title = {Whole-Exome Sequencing Utility and Drug Resistance in a Real-World Epilepsy Cohort from Southern Kazakhstan},
  journal = {International Journal of Translational Medicine},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {30},
  doi = {10.3390/ijtm6030030}
}
Kostenlos starten →